ZGG-18068-30914 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-01-16
Registered in v-safe
2021-01-16
Dose 1 — Pfizer-BioNTech
2021-01-16
Health check-in — day 0, dose 1
Feeling: Good · None

Adult check-in
2021-01-17
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2021-01-18
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2021-01-19
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Headache

Adult check-in
2021-01-20
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2021-01-21
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2021-01-22
Health check-in — days 1–6 daily, dose 1
Feeling: Fair · Fatigue or tiredness

Adult check-in
2021-01-23
Health check-in — day 7, dose 1
Feeling: Good · None

Adult check-in
2021-01-30
Health check-in — day 14, dose 1
Feeling: Good

Adult check-in
2021-02-03
Dose 2 — Pfizer-BioNTech
2021-02-13
Health check-in — day 7, dose 2
Feeling: Good · None

Adult check-in
2021-02-17
Health check-in — day 14, dose 2
Feeling: Good

Adult check-in
2021-02-24
Health check-in — day 21, dose 2
Feeling: Good

Adult check-in
2021-03-03
Health check-in — day 28, dose 2
Feeling: Good

Adult check-in
2021-03-10
Survey response — day 35, dose 2
MedDRA: Muscle spasms, Myalgia — Feeling: Fair

Free text: Noted over past 2-3 weeks, persistent and reoccurring myalgia and muscle cramping. Unable to associate it with any particular activity. Cramping occurring primarily at night.

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-03-17
Health check-in — day 42, dose 2
Feeling: Good

Adult check-in
2021-05-05
Health check-in — 3 months, dose 2
Feeling: Good

Adult check-in
2022-02-03
Survey response — 12 months, dose 2
MedDRA: Chest pain, Chills, Cough, Dyspnoea, Headache, Myalgia, Neuropathy peripheral, Oropharyngeal pain, Pyrexia, Rhinorrhoea, SARS-CoV-2 test positive — Feeling: Fair · Be unable to do your normal daily activities

Free text: Positive rapid Covid test 1/22/22. Onset fever, chills, myalgia, runny nose, sore throat, headache, and cough. Fever resolved 2/25 . Persistent cough, headache accompanied by intermittent breathlessness and chest wall burning, peripheral neuropathy.

MedDRA releases: 2024-11 · check-in free text available

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-01-16	Pfizer-BioNTech
2	2021-02-03	Pfizer-BioNTech

Free text

Release 5 — day 35, dose 2

2021-03-10

Symptoms: Noted over past 2-3 weeks, persistent and reoccurring myalgia and muscle cramping. Unable to associate it with any particular activity. Cramping occurring primarily at night.

Release 11 — 12 months, dose 2

2022-02-03

Symptoms: Positive rapid Covid test 1/22/22. Onset fever, chills, myalgia, runny nose, sore throat, headache, and cough. Fever resolved 2/25 . Persistent cough, headache accompanied by intermittent breathlessness and chest wall burning, peripheral neuropathy. cut off by CDC

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Chest pain	·	·	✓
SD	Chills	·	·	✓
SD	Cough	·	·	✓
SD	Dyspnoea	·	·	✓
SD	Headache	·	·	✓
SD	Muscle spasms	✓	✓	✓
SD	Myalgia	✓	✓	✓
SD	Neuropathy peripheral	·	·	✓
SD	Oropharyngeal pain	·	·	✓
SD	Pyrexia	·	·	✓
SD	Rhinorrhoea	·	·	✓
SD	SARS-CoV-2 test positive	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release